Logo image of ACRV

ACRIVON THERAPEUTICS INC (ACRV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ACRV - US0048901096 - Common Stock

1.94 USD
-0.11 (-5.37%)
Last: 1/26/2026, 8:00:00 PM
1.91 USD
-0.03 (-1.55%)
Pre-Market: 1/27/2026, 6:22:49 AM
Fundamental Rating

3

Overall ACRV gets a fundamental rating of 3 out of 10. We evaluated ACRV against 525 industry peers in the Biotechnology industry. ACRV has a great financial health rating, but its profitability evaluates not so good. ACRV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ACRV has reported negative net income.
  • In the past year ACRV has reported a negative cash flow from operations.
  • In the past 5 years ACRV always reported negative net income.
  • In the past 5 years ACRV always reported negative operating cash flow.
ACRV Yearly Net Income VS EBIT VS OCF VS FCFACRV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -56.26%, ACRV perfoms like the industry average, outperforming 44.57% of the companies in the same industry.
  • ACRV's Return On Equity of -63.57% is in line compared to the rest of the industry. ACRV outperforms 59.43% of its industry peers.
Industry RankSector Rank
ROA -56.26%
ROE -63.57%
ROIC N/A
ROA(3y)-33.95%
ROA(5y)-71.69%
ROE(3y)-37.89%
ROE(5y)-107.72%
ROIC(3y)N/A
ROIC(5y)N/A
ACRV Yearly ROA, ROE, ROICACRV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • ACRV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACRV Yearly Profit, Operating, Gross MarginsACRV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, ACRV has more shares outstanding
  • There is no outstanding debt for ACRV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACRV Yearly Shares OutstandingACRV Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
ACRV Yearly Total Debt VS Total AssetsACRV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ACRV has an Altman-Z score of -1.33. This is a bad value and indicates that ACRV is not financially healthy and even has some risk of bankruptcy.
  • ACRV has a Altman-Z score (-1.33) which is comparable to the rest of the industry.
  • ACRV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.33
ROIC/WACCN/A
WACCN/A
ACRV Yearly LT Debt VS Equity VS FCFACRV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • ACRV has a Current Ratio of 8.75. This indicates that ACRV is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 8.75, ACRV is doing good in the industry, outperforming 77.71% of the companies in the same industry.
  • ACRV has a Quick Ratio of 8.75. This indicates that ACRV is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 8.75, ACRV is doing good in the industry, outperforming 77.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.75
Quick Ratio 8.75
ACRV Yearly Current Assets VS Current LiabilitesACRV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.11% over the past year.
EPS 1Y (TTM)21.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ACRV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.33% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y16.05%
EPS Next 2Y9.78%
EPS Next 3Y5.3%
EPS Next 5Y6.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACRV Yearly Revenue VS EstimatesACRV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
ACRV Yearly EPS VS EstimatesACRV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4 -6

0

4. Valuation

4.1 Price/Earnings Ratio

  • ACRV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACRV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACRV Price Earnings VS Forward Price EarningsACRV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACRV Per share dataACRV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.78%
EPS Next 3Y5.3%

0

5. Dividend

5.1 Amount

  • ACRV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACRIVON THERAPEUTICS INC / ACRV FAQ

Can you provide the ChartMill fundamental rating for ACRIVON THERAPEUTICS INC?

ChartMill assigns a fundamental rating of 3 / 10 to ACRV.


What is the valuation status of ACRIVON THERAPEUTICS INC (ACRV) stock?

ChartMill assigns a valuation rating of 0 / 10 to ACRIVON THERAPEUTICS INC (ACRV). This can be considered as Overvalued.


Can you provide the profitability details for ACRIVON THERAPEUTICS INC?

ACRIVON THERAPEUTICS INC (ACRV) has a profitability rating of 1 / 10.


How financially healthy is ACRIVON THERAPEUTICS INC?

The financial health rating of ACRIVON THERAPEUTICS INC (ACRV) is 7 / 10.